Blocker Oligonucleotides for Probe Silencing in Spatial Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for spatial analysis of biological samples using templated ligation fail to selectively silence probes targeting highly expressed analytes, leading to off-target detection and reduced efficiency in determining analyte location and abundance.

Innovation Solution

The use of antisense synthetic molecules, such as blocker oligonucleotides, to selectively silence probes in templated ligation processes, thereby improving the detection of specific analytes by blocking hybridization with undesired probes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If capture probes are used to detect analytes by hybridizing to poly(A) tail, then a high number of analytes can be detected, but off-target analytes are also detected reducing measurement precision

Engineering Contradiction:
Improvenumber of analytes detectedVSAvoidspecificity of analyte detection
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The probe is divided into multiple functional domains: a capture domain for specific analyte binding, a spacer region for structural separation, and a barcode sequence for identification. This segmentation allows the probe to maintain high specificity through the capture domain while enabling comprehensive detection through the barcode system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A barcode sequence acts as an intermediary between the specific capture domain and the detection system. The barcode is linked to the capture domain but does not directly interact with the analyte, allowing indirect detection that maintains specificity while enabling high-throughput analysis of multiple analytes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If probes targeting highly expressed analytes are used, then detection sensitivity for those analytes is high, but sequencing saturation occurs reducing productivity

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsequencing throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The system changes the concentration parameter of probe-barcode complexes in solution, allowing highly expressed analytes to be detected at lower probe concentrations, thereby reducing sequencing saturation while maintaining detection sensitivity through optimized binding kinetics.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If blocker oligonucleotides are added to silence specific probes, then detection specificity is improved, but device complexity increases

Engineering Contradiction:
Improvedetection specificityVSAvoidnumber of reagents required
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Blocker oligonucleotides are designed to self-complement with specific probe sequences, allowing them to automatically silence off-target probes without requiring external control mechanisms. The blockers perform their silencing function autonomously through hybridization, reducing the need for complex regulatory systems.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the number of genes detected, sensitivity, and spatial diversity in spatial analysis by up to 100% and reduces sequencing saturation levels by up to 50% compared to methods without blocker oligonucleotides.

Implementation Method 1

By designing synthetic molecules that are antisense to probes to be silenced, one can selectively silence such probes and block hybridization with their target analytes

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentEP4352252B1Methods for spatial analysis using targeted probe silencing
Publication Date: 2026.01.28 10X GENOMICS INC
  • EP4352252B1 patent drawingFigure 1
  • EP4352252B1 patent drawingFigure 2
  • EP4352252B1 patent drawingFigure 3

AI summary

Provided herein are methods for selective silencing of one or more probes used in templated ligation, or RNA-templated ligation. In some embodiments, the selective silencing is achieved using one or more blocker oligonucleotides.